N4 Pharma Plc (N4P.L) Research
N4 Pharma Plc is a specialized pharmaceutical company dedicated to creating advanced silica nanoparticle delivery platforms for pharmaceutical and biotechnology organizations throughout the United Kingdom. A core product is Nuvec, a non-viral adjuvant delivery system specifically designed for use in vaccine development and cancer therapies. Founded in 1979, the company is headquartered in London, UK.
Market snapshot
- Symbol
- N4P.L
- Price
- $0.48
- Day change
- 0.00%
- Market cap
- $4.0M
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Open N4 Pharma Plc (N4P.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.